SUNESIS PHARMACEUTICALS INC Underwriting Agreements
13 Contracts & Agreements
- Underwriting Agreement relating to the Offering, dated July 29, 2020 (Filed With SEC on July 31, 2020)
- Underwriting Agreement relating to the Series F Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
- Underwriting Agreement relating to the Common Stock Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
- Underwriting Agreement relating to the Series E Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
- Underwriting Agreement relating to the Common Stock Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
- Underwriting Agreement relating to the Series D Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)
- Underwriting Agreement relating to the Common Stock Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)
- 1,558 Shares SUNESISPHARMACEUTICALS, INC. Series C Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)
- 4,935,500 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)
- 20,200 Shares SUNESISPHARMACEUTICALS, INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)
- 9,561,905 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)
- 4,650,000 Shares Series A Warrants to Purchase 4,650,000 Shares Series B Warrants to Purchase 4,650,000 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 27, 2014)
- 4,750,000 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share UNDERWRITING AGREEMENT (Filed With SEC on May 24, 2007)
